News

Biotech cools off in August as capital markets weaken September 01, 2010 | Press Release

Biotech gets hot in July August 02, 2010 | Press Release

Shawn Cross appointed CEO of Burrill Merchant Banking Group July 28, 2010 | Press Release

  See all News
Sign up to receive email notifications about our upcoming events and news.


Submit a Business Plan

Do great things with us.Click here 
Venture Capital

Paul Berg—Cahill Professor in Biochemistry, Emeritus, Stanford University; Director, Emeritus, Beckman Center for Molecular and Genetic Medicine at Stanford; Nobel Laureate in Chemistry

Carl Feldbaum—President Emeritus, Biotechnology Industry Organization.

Frederick Frank—Vice Chairman and Director, Lehman Brothers.

Martin Gerstel—Chairman of Compugen, Keddem Bioscience and Evogene; Co-Chairman of Itamar Medical; former Co-Chairman and CEO of ALZA Corporation

Lee Hood—President of The Institute for Systems Biology

David M. Lawrence—Chairman and CEO (retired), Kaiser Foundation Health Plan and Hospitals

George Poste—CEO, Health Technology Networks; Director, The Biodesign Institute, Arizona State University; former CSTO and head of R&D, SmithKline Beecham

Tommy Thompson—Former Secretary of Health & Human Services; former Governor of Wisconsin; BLSCF II Advisory Board